A detailed history of Greenwood Capital Associates LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 5,580 shares of EW stock, worth $378,100. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,580
Previous 55,815 90.0%
Holding current value
$378,100
Previous $5.16 Million 92.86%
% of portfolio
0.05%
Previous 0.69%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$59.7 - $93.78 $3 Million - $4.71 Million
-50,235 Reduced 90.0%
5,580 $368,000
Q2 2024

Aug 08, 2024

SELL
$84.3 - $94.31 $2.49 Million - $2.78 Million
-29,495 Reduced 34.57%
55,815 $5.16 Million
Q1 2024

May 01, 2024

SELL
$72.54 - $95.56 $474,629 - $625,249
-6,543 Reduced 7.12%
85,310 $8.15 Million
Q4 2023

Mar 05, 2024

BUY
$61.71 - $77.76 $96,452 - $121,538
1,563 Added 1.73%
91,853 $7 Million
Q3 2023

Oct 18, 2023

SELL
$69.28 - $93.38 $1.5 Million - $2.03 Million
-21,693 Reduced 19.37%
90,290 $6.26 Million
Q2 2023

Aug 07, 2023

BUY
$81.41 - $94.33 $1.26 Million - $1.46 Million
15,492 Added 16.06%
111,983 $10.6 Million
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $7.17 Million - $8.15 Million
96,491 New
96,491 $7.98 Million
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $249,917 - $306,621
-5,385 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $3,427 - $4,352
75 Added 1.41%
5,385 $938,000
Q2 2018

Aug 07, 2018

BUY
$42.45 - $51.3 $128,496 - $155,285
3,027 Added 132.59%
5,310 $773,000
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $11,789 - $15,041
317 Added 16.12%
2,283 $319,000
Q4 2017

Feb 02, 2018

BUY
$33.79 - $39.39 $439 - $512
13 Added 0.67%
1,966 $222,000
Q3 2017

Nov 03, 2017

BUY
$36.29 - $38.83 $70,874 - $75,834
1,953
1,953 $213,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.